Euthymed 50 - Driada Medical

Levothyroxine sodium, first marketed in 1955 by Flint Laboratories as Synthroid®, was the earliest synthetic thyroid hormone available in the U.S. It replaces T4, a hormone crucial for regulating metabolism and energy balance. While primarily used to treat hypothyroidism, it became popular in bodybuilding for its ability to accelerate fat loss during cutting phases. In the 1990s, controversy arose when suppressed research showed generic versions were equally effective. This led to a $135 million settlement and reshaped perceptions of thyroid hormone therapy’s pharmaceutical landscape.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Euthymed 50 by Driada Medical, consult with your doctor or healthcare professional.